Literature DB >> 3060822

Evaluation of the RapID ANA system as a four-hour method for anaerobe identification.

J Downes1, J H Andrew.   

Abstract

The RapID ANA system (Innovative Diagnostic Systems Inc., Atlanta, Ga, USA), a 4-hour micromethod for identifying clinically important anaerobic bacteria, was evaluated using 196 anaerobic clinical isolates and the results were compared with those obtained by applying conventional Virginia Polytechnic Institute (VPI) methodology. The identifications achieved by the RapID ANA system for 141 (72%) of these isolates agreed with the species identifications obtained using VPI methodology, without the need for additional tests. A further 40 (20%) were in agreement after performance of additional suggested tests, 11 (6%) were misidentified and 4 (2%) could not be identified using the RapID ANA system. Excellent agreement between the two methods was demonstrated for the Gram-positive cocci and good agreement for the Gram-negative bacilli. The RapID ANA system was suboptimal in the identification of Clostridium species other than C. perfringens.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3060822     DOI: 10.3109/00313028809059503

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  3 in total

1.  Evaluation of the new RapID-ANA II system for the identification of clinical anaerobic isolates.

Authors:  L M Marler; J A Siders; L C Wolters; Y Pettigrew; B L Skitt; S D Allen
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

2.  Clinical evaluation of the RapID-ANA II panel for identification of anaerobic bacteria.

Authors:  D M Celig; P C Schreckenberger
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Multicenter evaluation of the Vitek 2 anaerobe and Corynebacterium identification card.

Authors:  Robert P Rennie; Cheryl Brosnikoff; LeeAnn Turnbull; L Barth Reller; Stanley Mirrett; William Janda; Kathy Ristow; Ann Krilcich
Journal:  J Clin Microbiol       Date:  2008-06-18       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.